Rango del día
$29.52 - $30.02
Cierre Anterior
$29.75
Rango de 52 semanas
$25.20 - $34.11
Volumen
23M
Capitalización de Mercado
$168.07B
Sector
Healthcare
Industry
Drug Manufacturers General
Country
US
Website
http://www.pfizer.com

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; a material transfer and collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; and a multi-target drug discovery collaboration with Sosei Group Corporation. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Este contenido ha sido generado mediante un modelo de lenguaje de inteligencia artificial. Si bien nos esforzamos por lograr precisión y calidad, tenga en cuenta que es posible que la información proporcionada no esté completamente libre de errores o no esté actualizada. Recomendamos verificar de forma independiente el contenido y consultar con profesionales para obtener información específica. No asumimos ninguna responsabilidad por el uso o interpretación de este contenido. También tenga en cuenta que la información que se encuentra en la plataforma easyMarkets pretende ser únicamente informativa, no es un consejo ni una recomendación, ni una investigación, ni un registro de nuestros precios de negociación, ni una oferta o solicitud de una transacción en ningún instrumento financiero y por lo tanto no debe ser tratado como tal. La información proporcionada no involucra ningún objetivo de inversión específico, situación financiera ni necesidades de ninguna persona específica que pueda recibirla. Tenga en cuenta que el rendimiento pasado no es un indicador fiable del rendimiento y/o resultados futuros.